Immunogen reported $0 in Loan Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Acceleron Pharma XLRN:US $ 0M 0M
Agios Pharmaceuticals AGIO:US $ 0M 0.17M
Amgen AMGN:US $ 33291M 4833M
Arena Pharmaceuticals ARNA:US $ 37.48M 1.3M
Astellas Pharma 4503:JP Y 204838M 3476M
AstraZeneca AZN:LN 28939M 4338M
Bluebird Bio BLUE:US $ 0M 0M
Bristol Myers Squibb BMY:US $ 39677M 2826M
Cerulean Pharma CERU:US $ 0 0
Dicerna Pharmaceuticals DRNA:US $ 0M 0M
Eli Lilly And LLY:US $ 15522.4M 785.8M
Emergent Biosolutions EBS:US $ 817.3M 7.9M
Exelixis EXEL:US $ 0M 0M
Halozyme Therapeutics HALO:US $ 786.45M 0.88M
Karyopharm Therapeutics KPTI:US $ 301.57M 195K
Macrogenics MGNX:US $ 0 0
Nektar Therapeutics NKTR:US $ 0M 0M
Novartis NVS:US $ 24715M 1776M
Regeneron Pharmaceuticals REGN:US $ 1979.6M 0.4M
Seattle Genetics SGEN:US $ 0M 0M